32 results on '"Zhou, Shuaixiang"'
Search Results
2. IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
3. Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
4. Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy
5. Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity
6. Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody
7. Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity
8. Development and characterization of a novel anti-OX40 antibody for potent immune activation
9. Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance
10. Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
11. IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma
12. Opportunities and challenges from current investigations into the biosynthetic logic of nosiheptide-represented thiopeptide antibiotics
13. Thioredoxin Redox Regulates ATPase Activity of Magnesium Chelatase CHLI Subunit and Modulates Redox-Mediated Signaling in Tetrapyrrole Biosynthesis and Homeostasis of Reactive Oxygen Species in Pea Plants
14. Structure of IgG-Fc hexamer reveals a mutual lock-and-key mode of Fc-Fc interaction
15. Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody
16. Optimal Target Saturation of Ligand-Blocking Anti-GITR Antibody IBI37G5 Dictates FcγR-Independent GITR Agonism and Antitumor Activity
17. PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity
18. IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
19. Abstract 2268: The PD-L1 and OX40 bispecific antibody IBI327 induces immune activation and improves cancer immunotherapy
20. Abstract 3270: Dual blockade of PD-L1 and LAG-3 using a bispecific antibody improves anti-tumor immunity
21. Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity
22. Dose escalation PET imaging for safety and effective therapy dose optimization of a bispecific antibody
23. Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit
24. Radical S-Adenosylmethionine Protein NosN Forms the Side Ring System of Nosiheptide by Functionalizing the Polythiazolyl Peptide S-Conjugated Indolic Moiety
25. Thiolation Protein-Based Transfer of Indolyl to a Ribosomally Synthesized Polythiazolyl Peptide Intermediate during the Biosynthesis of the Side-Ring System of Nosiheptide
26. Processing 2-Methyl-l-Tryptophan through Tandem Transamination and Selective Oxygenation Initiates Indole Ring Expansion in the Biosynthesis of Thiostrepton
27. 1-N-histidine phosphorylation of ChlD by the AAA+ ChlI2 stimulates magnesium chelatase activity in chlorophyll synthesis
28. GUN4-Protoporphyrin IX Is a Singlet Oxygen Generator with Consequences for Plastid Retrograde Signaling
29. C-terminal residues of Oryza sativa GUN4 are required for the activation of the ChlH subunit of magnesium chelatase in chlorophyll synthesis
30. An enzymatic [4+2] cyclization cascade creates the pentacyclic core of pyrroindomycins
31. Inducing the oxidative stress response in Escherichia coli improves the quality of a recombinant protein: Magnesium chelatase ChlH
32. 1- N -histidine phosphorylation of ChlD by the AAA + ChlI2 stimulates magnesium chelatase activity in chlorophyll synthesis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.